ライフサイエンスコーパス: pathologic diagnosis

1 sus and communication between endoscopic and pathologic diagnosis.

2 inical, II) imaging-supported, III) definite pathologic diagnosis.

3 standardized, objective results to assist in pathologic diagnosis.

4 87% end-to-side pancreaticojejunostomy), and pathologic diagnosis.

5 sensitivity and specificity for each IGCNBB pathologic diagnosis.

6 ists assess the need to perform a biopsy for pathologic diagnosis.

7 four independent radiologists blinded to the pathologic diagnosis.

8 based on sufficient signal and postanalysis pathologic diagnosis.

9 The reference standard was pathologic diagnosis.

10 For lesions without a pathologic diagnosis, 712 (70.0%) were followed for as l

11 hm, and the reference standard was an expert pathologic diagnosis according to WHO classification.

12 ignant samples were predominantly stage 1 by pathologic diagnosis and 97% of the benign samples were

13 2, and June 12, 2020, were analyzed by final pathologic diagnosis and antibody subtype positivity, in

14 gs, laboratory workup, treatment, follow-up, pathologic diagnosis, and histopathologic inflammation p

15 r of five biopsies (80%) yielded an accurate pathologic diagnosis, and one biopsy specimen showed ben

16 d its relationship to tumor characteristics, pathologic diagnosis, and operative outcomes.

17 and laboratory findings, extent of surgery, pathologic diagnosis, and staging.

18 arietal hypometabolism were determined using pathologic diagnosis as the gold standard.

19 c accuracy measures were calculated by using pathologic diagnosis as the reference standard, as well

20 The renal pathologic diagnosis as well as the percent tubular atro

21 's lymphoma (NHL) database with a documented pathologic diagnosis before presentation and a final pat

22 ancement were used to estimate the effect of pathologic diagnosis (benign vs malignant), lesion type

23 Fibromuscular dysplasia is a pathologic diagnosis, but the characteristic changes see

24 porting and Data System (PI-RADS) scores and pathologic diagnosis drew regions of interest on cancer-

25 Pathologic diagnosis for all patients was confirmed usin

26 tal changes, outcome at follow-up, and final pathologic diagnosis, if malignant.

27 istologic tissue samples were sufficient for pathologic diagnosis in 24 of 26 cases.

28 The pathologic diagnosis in core samples with and those with

29 Five readers, blinded to pathologic diagnosis, independently evaluated all cases

30 Pathologic diagnosis is challenging because of lesional

31 l diagnosis, operative management to confirm pathologic diagnosis is warranted.

32 Then, it was a pathologic diagnosis, life expectancy was approximately

33 fication provides a much needed standard for pathologic diagnosis not only for patient care but also

34 Myocarditis is an uncommon pathologic diagnosis occurring in 4.5% of highly selecte

35 The pathologic diagnosis of AD still remains the gold standa

36 Although beta-amyloid is necessary for the pathologic diagnosis of AD, it is not sufficient to make

37 Outcomes included pathologic diagnosis of Alzheimer disease (AD), global A

38 jects and was marginally associated with the pathologic diagnosis of Alzheimer disease (CD4+) or amyl

39 TDP-43 pathology combined with a pathologic diagnosis of Alzheimer's disease was a common

40 imer's-type dementia formerly labelled 'pure pathologic diagnosis of Alzheimer's disease' was halved

41 66%) subjects with Lewy body pathology had a pathologic diagnosis of Alzheimer's disease.

42 ic diagnosis before presentation and a final pathologic diagnosis of any of five common B-cell NHLs w

43 were significantly more likely to have a new pathologic diagnosis of cancer compared with patients wi

44 Findings of all image-guided biopsies with a pathologic diagnosis of DCIS during a 1-year period were

45 ctors favoring long-term survival included a pathologic diagnosis of duodenal adenocarcinoma, tumor d

46 Patients with a pathologic diagnosis of dysplasia in Crohn's colitis fro

47 nt, and outcome of pediatric patients with a pathologic diagnosis of FNH to provide additional data t

48 diatric patients were identified as having a pathologic diagnosis of FNH, either by biopsy sample (n

49 (i) biology of HER2-low breast cancer; (ii) pathologic diagnosis of HER2-low breast cancer; (iii) cl

50 Criteria are presented for the pathologic diagnosis of IgG4-related aortitis.

51 hology core and 54 of 91 patients received a pathologic diagnosis of IPF.

52 analyzed additional samples with a confirmed pathologic diagnosis of late-onset Alzheimer disease (LO

53 The medical records of 71 patients with a pathologic diagnosis of LCH, age 0 to 21 years, who pres

54 The pathologic diagnosis of lentigo maligna was established

55 Ninety-six patients had a final pathologic diagnosis of lung cancer.

56 ving definitions for LDN templates, means of pathologic diagnosis of lymph nodes, as well as implicat

57 widely used to obtain tissue for definitive pathologic diagnosis of mammographically suspicious brea

58 review revealed 25 patients with an initial pathologic diagnosis of medullary carcinoma.

59 The outcome was pathologic diagnosis of NASH.

60 Group 1 included 17 patients with the pathologic diagnosis of PFE who also underwent echocardi

61 termine the correlation between clinical and pathologic diagnosis of PTMA, to define the precise morp

62 ression in PBLs is closely associated with a pathologic diagnosis of rejection.

63 e of SIGEI may be a helpful criterion in the pathologic diagnosis of renal allografts.

64 graft eosinophilic infiltrate (SIGEI) to the pathologic diagnosis of renal transplants.

65 The accurate pathologic diagnosis of retinal hemorrhages has critical

66 Pathologic diagnosis of the PET-positive mass showed onl

67 the goal of providing useful adjuncts to the pathologic diagnosis of this complex disease.

68 opkins Hospital between 1957 and 1997 with a pathologic diagnosis of thymoma.

69 Body mass index greater than 30, final pathologic diagnosis of ulcerative/indeterminate colitis

70 mass index > 30 (P = 0.02, OR = 1.77), final pathologic diagnosis of ulcerative/indeterminate colitis

71 osis of AD, it is not sufficient to make the pathologic diagnosis or cause dementia.

72 All masses had a pathologic diagnosis or resolved after anticoagulation.

73 e study protocol and who either were given a pathologic diagnosis or underwent follow-up imaging.

74 inded to all clinical information, including pathologic diagnosis, patient information, and outcomes.

75 tional trans-sternal thymectomy, neither the pathologic diagnosis (presence of thymoma) nor the age a

76 Pathologic diagnosis requires labor-intensive reading of

77 ified by abdominal CT and by postnephrectomy pathologic diagnosis, respectively.

78 A new pathologic diagnosis resulted in change in medical manag

79 Seven readers blinded to pathologic diagnosis scored gray-scale US and optoacoust

80 Survival was determined from pathologic diagnosis to death.

81 ts with lymphoma and correlated results with pathologic diagnosis using the World Health Organization

82 A pathologic diagnosis was available for all 94 lesions; 3

83 een September 2002 and June 2004, for whom a pathologic diagnosis was available.

84 considered clinically important if the final pathologic diagnosis was cancerous, precancerous, or non

85 ma classification system, disagreement about pathologic diagnosis was common.

86 the percent infiltrate were varied, and the pathologic diagnosis was compared with the clinical cour

87 mens from the patients were retrieved, their pathologic diagnosis was confirmed, demographic and clin

88 clusion criteria for the study, the original pathologic diagnosis was ENOS in 49 patients (84%).